IMPLANT TREATMENT PLANNING CERTIFICATION EXAM
PRACTICE QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES Q&A INSTANT DOWNLOAD PDF
140 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Critically evaluate patient-specific factors influencing implant treatment outcomes
2 Integrate advanced imaging and digital planning tools to formulate comprehensive treatment plans
3 Apply risk assessment and evidence-based protocols to manage complex implant cases
4 Synthesize interdisciplinary knowledge to address restorative, surgical, and biomechanical challenges
5 Implant Treatment Planning Certification Exam Practice Questions And Correct Answers
6 Verified Answers
7 Plus Rationales Q&A Instant Download Pdf
8 Foundations of Implant Treatment Planning
9 Applied Implant Treatment Planning
10 Advanced Implant Treatment Planning
11 Implant Treatment Planning Review
Page 1
,Q1 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
A patient presents with a healed anterior maxillary extraction site and a thick
gingival biotype. Cone-beam CT reveals a buccal bone plate thickness of 0.8 mm
at the crest and 1.2 mm at the mid-root level. Which treatment planning approach
is most evidence-based to minimize the risk of buccal bone resorption and soft
tissue recession?
A. Immediate implant placement with a flapless approach and provisional restoration
B. Delayed implant placement with simultaneous guided bone regeneration (GBR) CORRECT
C. Immediate implant placement with a xenogeneic graft and a resorbable membrane
D. Socket preservation with a dense PTFE membrane and delayed implant placement
RATIONALE: Delayed implant placement with GBR is indicated when the buccal bone is thin (<1
mm) to allow for socket healing and simultaneous augmentation, reducing resorption risk.
Immediate placement in thin bone is associated with higher recession. Socket preservation alone
does not address the need for implant-level bone augmentation. Immediate placement with
grafting does not prevent the initial resorption that occurs during healing.
Q2 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
In a patient with a history of intravenous bisphosphonate use for 5 years, which of
the following is the most critical factor in deciding whether to proceed with
implant placement?
A. The patient's age and gender
B. The duration of bisphosphonate therapy and drug holiday CORRECT
C. The serum level of C-terminal telopeptide (CTX)
D. The type of bisphosphonate (nitrogen-containing vs. non-nitrogen-containing)
RATIONALE: The risk of medication-related osteonecrosis of the jaw (MRONJ) is primarily
related to the cumulative dose and duration of bisphosphonate therapy. A drug holiday, if feasible,
may reduce risk, but the duration is a more critical factor than a single CTX value, which is not a
reliable predictor. Age, gender, and specific bisphosphonate type are less decisive than overall
exposure duration.
Page 2
,Q3 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
Which of the following best explains the biomechanical advantage of a
platform-switched implant connection in reducing peri-implant bone loss?
A. It increases the distance between the implant-abutment junction and the bone crest
B. It shifts the inflammatory infiltrate medially, away from the crestal bone CORRECT
C. It increases the diameter of the abutment, distributing stress over a larger area
D. It eliminates micro-movements at the implant-abutment interface
RATIONALE: Platform switching moves the implant-abutment junction inward, which relocates
the inflammatory cell infiltrate and stress concentration away from the crestal bone, thereby
reducing bone resorption. Increasing the distance (A) is a consequence but not the primary
mechanism. Platform switching does not increase abutment diameter (C) nor eliminate
micro-movements (D).
Q4 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
A patient requires replacement of a single mandibular first molar. Radiographic
analysis shows a mesiodistal space of 11 mm and an interocclusal distance of 6
mm. Using standard implant dimensions, which implant diameter and prosthetic
component selection is most appropriate to maintain a favorable emergence
profile and avoid biomechanical overload?
A. 4.0 mm implant with a 5.0 mm abutment and a screw-retained crown
B. 5.0 mm implant with a 4.5 mm abutment and a cemented crown
C. 4.5 mm implant with a 4.5 mm abutment and a screw-retained crown CORRECT
D. 5.5 mm implant with a 5.5 mm abutment and a cemented crown
RATIONALE: The mesiodistal space of 11 mm allows for a 4.5 mm implant with a 1.5 mm
minimum distance to adjacent teeth. The interocclusal distance of 6 mm is adequate for a
screw-retained crown, which avoids cement issues. A 4.0 mm implant may be too narrow for a
molar, while 5.0 mm and 5.5 mm implants with matching abutments may not leave enough space
for bone and soft tissue, and cemented crowns risk cement extrusion.
Page 3
, Q5 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
Which of the following is the most accurate statement regarding the use of
platelet-rich fibrin (PRF) in implant site development?
A. PRF consistently enhances new bone formation when mixed with particulate bone grafts
B. PRF acts as a scaffold and growth factor reservoir but has limited osteoinductive potential
CORRECT
C. PRF should be used as a substitute for barrier membranes in guided bone regeneration
D. PRF improves osseointegration by directly stimulating osteoblast differentiation
RATIONALE: PRF provides a fibrin scaffold and releases growth factors that may aid soft tissue
healing and graft maturation, but it lacks osteoinductive properties (no bone morphogenetic
proteins) and is not a replacement for barrier membranes. Its effect on bone regeneration is not
consistently proven, and it does not directly stimulate osteoblast differentiation in a manner
comparable to BMPs.
Q6 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
In a patient with a fully edentulous maxilla and severe resorption, a fixed
implant-supported prosthesis is planned. Which of the following is a critical
consideration when choosing between a fixed complete denture (FCD) and a
removable implant-supported overdenture?
A. The number of implants required is always higher for an overdenture
B. The FCD requires a minimum of four implants with distal cantilevers
C. The overdenture allows for easier oral hygiene maintenance and is more cost-effective
CORRECT
D. The FCD provides better lip support and esthetics than an overdenture
RATIONALE: Overdentures are removable, facilitating hygiene and typically requiring fewer
implants (often 2-4) and lower cost. FCDs usually require more implants and may have
cantilevers, but not always. Lip support and esthetics are often better with overdentures due to
the flange, while FCDs may lack that support. Thus, C is the most accurate.
Page 4
PRACTICE QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES Q&A INSTANT DOWNLOAD PDF
140 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Critically evaluate patient-specific factors influencing implant treatment outcomes
2 Integrate advanced imaging and digital planning tools to formulate comprehensive treatment plans
3 Apply risk assessment and evidence-based protocols to manage complex implant cases
4 Synthesize interdisciplinary knowledge to address restorative, surgical, and biomechanical challenges
5 Implant Treatment Planning Certification Exam Practice Questions And Correct Answers
6 Verified Answers
7 Plus Rationales Q&A Instant Download Pdf
8 Foundations of Implant Treatment Planning
9 Applied Implant Treatment Planning
10 Advanced Implant Treatment Planning
11 Implant Treatment Planning Review
Page 1
,Q1 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
A patient presents with a healed anterior maxillary extraction site and a thick
gingival biotype. Cone-beam CT reveals a buccal bone plate thickness of 0.8 mm
at the crest and 1.2 mm at the mid-root level. Which treatment planning approach
is most evidence-based to minimize the risk of buccal bone resorption and soft
tissue recession?
A. Immediate implant placement with a flapless approach and provisional restoration
B. Delayed implant placement with simultaneous guided bone regeneration (GBR) CORRECT
C. Immediate implant placement with a xenogeneic graft and a resorbable membrane
D. Socket preservation with a dense PTFE membrane and delayed implant placement
RATIONALE: Delayed implant placement with GBR is indicated when the buccal bone is thin (<1
mm) to allow for socket healing and simultaneous augmentation, reducing resorption risk.
Immediate placement in thin bone is associated with higher recession. Socket preservation alone
does not address the need for implant-level bone augmentation. Immediate placement with
grafting does not prevent the initial resorption that occurs during healing.
Q2 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
In a patient with a history of intravenous bisphosphonate use for 5 years, which of
the following is the most critical factor in deciding whether to proceed with
implant placement?
A. The patient's age and gender
B. The duration of bisphosphonate therapy and drug holiday CORRECT
C. The serum level of C-terminal telopeptide (CTX)
D. The type of bisphosphonate (nitrogen-containing vs. non-nitrogen-containing)
RATIONALE: The risk of medication-related osteonecrosis of the jaw (MRONJ) is primarily
related to the cumulative dose and duration of bisphosphonate therapy. A drug holiday, if feasible,
may reduce risk, but the duration is a more critical factor than a single CTX value, which is not a
reliable predictor. Age, gender, and specific bisphosphonate type are less decisive than overall
exposure duration.
Page 2
,Q3 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
Which of the following best explains the biomechanical advantage of a
platform-switched implant connection in reducing peri-implant bone loss?
A. It increases the distance between the implant-abutment junction and the bone crest
B. It shifts the inflammatory infiltrate medially, away from the crestal bone CORRECT
C. It increases the diameter of the abutment, distributing stress over a larger area
D. It eliminates micro-movements at the implant-abutment interface
RATIONALE: Platform switching moves the implant-abutment junction inward, which relocates
the inflammatory cell infiltrate and stress concentration away from the crestal bone, thereby
reducing bone resorption. Increasing the distance (A) is a consequence but not the primary
mechanism. Platform switching does not increase abutment diameter (C) nor eliminate
micro-movements (D).
Q4 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
A patient requires replacement of a single mandibular first molar. Radiographic
analysis shows a mesiodistal space of 11 mm and an interocclusal distance of 6
mm. Using standard implant dimensions, which implant diameter and prosthetic
component selection is most appropriate to maintain a favorable emergence
profile and avoid biomechanical overload?
A. 4.0 mm implant with a 5.0 mm abutment and a screw-retained crown
B. 5.0 mm implant with a 4.5 mm abutment and a cemented crown
C. 4.5 mm implant with a 4.5 mm abutment and a screw-retained crown CORRECT
D. 5.5 mm implant with a 5.5 mm abutment and a cemented crown
RATIONALE: The mesiodistal space of 11 mm allows for a 4.5 mm implant with a 1.5 mm
minimum distance to adjacent teeth. The interocclusal distance of 6 mm is adequate for a
screw-retained crown, which avoids cement issues. A 4.0 mm implant may be too narrow for a
molar, while 5.0 mm and 5.5 mm implants with matching abutments may not leave enough space
for bone and soft tissue, and cemented crowns risk cement extrusion.
Page 3
, Q5 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
Which of the following is the most accurate statement regarding the use of
platelet-rich fibrin (PRF) in implant site development?
A. PRF consistently enhances new bone formation when mixed with particulate bone grafts
B. PRF acts as a scaffold and growth factor reservoir but has limited osteoinductive potential
CORRECT
C. PRF should be used as a substitute for barrier membranes in guided bone regeneration
D. PRF improves osseointegration by directly stimulating osteoblast differentiation
RATIONALE: PRF provides a fibrin scaffold and releases growth factors that may aid soft tissue
healing and graft maturation, but it lacks osteoinductive properties (no bone morphogenetic
proteins) and is not a replacement for barrier membranes. Its effect on bone regeneration is not
consistently proven, and it does not directly stimulate osteoblast differentiation in a manner
comparable to BMPs.
Q6 CRITICALLY EVALUATE PATIENT-SPECIFIC FACTORS INFLUENCING IMPLANT
TREATMENT OUTCOMES
In a patient with a fully edentulous maxilla and severe resorption, a fixed
implant-supported prosthesis is planned. Which of the following is a critical
consideration when choosing between a fixed complete denture (FCD) and a
removable implant-supported overdenture?
A. The number of implants required is always higher for an overdenture
B. The FCD requires a minimum of four implants with distal cantilevers
C. The overdenture allows for easier oral hygiene maintenance and is more cost-effective
CORRECT
D. The FCD provides better lip support and esthetics than an overdenture
RATIONALE: Overdentures are removable, facilitating hygiene and typically requiring fewer
implants (often 2-4) and lower cost. FCDs usually require more implants and may have
cantilevers, but not always. Lip support and esthetics are often better with overdentures due to
the flange, while FCDs may lack that support. Thus, C is the most accurate.
Page 4
